Selling Stem Cells: Ethical, Legal and Social Issues Related to U.S. Businesses Marketing Unlicensed Cell-based Interventions

Selling Stem Cells: Ethical, Legal and Social Issues Related to U.S. Businesses Marketing Unlicensed Cell-based Interventions

April 14, 2017

Address

727 E. Tyler St.
Tempe, AZ 85287

Location

Biodesign Institute, Auditorium

Date and Time

April 26, 2017, 2:00 pm (Length: 1 hour 0 minutes)

iCal Download

Leigh Turner, Ph.D., Associate Professor, Center for Bioethics, University of Minnesota

“Stem cell tourism” is a phrase used to describe journeys in which individuals with neurodegenerative diseases or other conditions seek care at facilities advertising stem cell therapies. Health researchers and journalists commonly depict cross-border trips in which patients travel to clinics in China, India, Mexico or elsewhere. Often implicit in such accounts is the assumption that “stem cell clinics” are based in countries with lax legislation and dysfunctional regulatory agencies whereas the U.S. has strict laws governing cellular therapies and vigilant regulatory bodies. Challenging this narrative, hundreds of U.S. businesses promote stem cell treatments, with Arizona having a particularly high concentration of such clinics. In addition to providing an empirical analysis of the current U.S. direct-to-consumer marketplace for stem cell interventions, this presentation will explore ethical, social and legal concerns related to such commercial activity.

This seminar is presented by the ASU School of Biological and Health Systems Engineering.